Document Details
Form
Filing Date
June 3, 2021
Document Date
June 2, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Protalix BioTherapeutics
Issuer
PROTALIX BIOTHERAPEUTICS, INC.
Filer
Dexcel Pharma Technologies Ltd.